News
SOLTF
6.10
NaN%
--
Nxera Pharma Secures Fourth AbbVie Milestone in Neurology Collaboration
TipRanks · 1d ago
Nxera Pharma Joins OpenFold AI Consortium to Boost GPCR Drug Discovery
TipRanks · 06/10 06:58
Nxera Wins Fast-Track and Orphan Status in Korea for Duchenne Drug Vamorolone
TipRanks · 06/01 23:46
Nxera trims RSU share issuance after partial forfeiture
TipRanks · 05/19 03:22
Nxera Pharma Progresses GPCR Program Via Spin-Out And Series A Financing
NASDAQ · 05/11 11:39
Nxera Pharma Spins Out Non-Core GPCR Program in NewCo Licensing and Series A Deal
TipRanks · 05/11 07:17
Nxera Pharma Returns to Profit on Surging Q1 Revenue, Keeps 2026 Guidance Unchanged
TipRanks · 05/01 07:04
Nxera Pharma Posts Strong Q1 2026 Momentum on Asia-Pacific Deals and Milestones
TipRanks · 05/01 07:04
Nxera Secures $10 Million Milestone From AbbVie
NASDAQ · 04/20 07:53
Nxera Pharma Secures Third AbbVie Milestone in Neurology Collaboration
TipRanks · 04/20 07:23
Nxera Pharma To Receive $10 Mln Milestone Payment From AbbVie Under Neurology Collaboration
NASDAQ · 04/20 06:53
Nxera Pharma Issues New Shares to Fund Japan Employee Stock Plan and Expand RSU Program
TipRanks · 04/15 07:52
Nxera Wins Taiwan Approval for QUVIVIQ Insomnia Drug, Eyes 2026 Launch
TipRanks · 04/14 07:28
Nxera Wins US$22.5m Milestone as Neurocrine Starts Phase 2 Schizophrenia Trial
TipRanks · 04/12 23:55
Nxera Pharma Hits Second Milestone in Lilly Metabolic Disease Partnership
TipRanks · 04/08 23:52
Lilly To Acquire Nxera's Partner Centessa Pharma In An Approx.$6.3 Bln Cash And $1.5 Bln CVR Deal
NASDAQ · 04/01 10:17
Lilly’s Centessa Deal Highlights Nxera Pharma’s GPCR Platform Strength
TipRanks · 04/01 05:04
Nxera Pharma Refreshes Board While Maintaining Core Leadership Team
TipRanks · 03/25 08:24
Nxera Pharma Secures $3 Million Milestone Payment from Centessa
TipRanks · 03/05 08:34
Nxera Pharma Co Files South Korea Marketing Application For Daridorexant
NASDAQ · 03/04 17:35
More
Webull provides a variety of real-time SOLTF stock news. You can receive the latest news about Nxera Pharma through multiple platforms. This information may help you make smarter investment decisions.
About SOLTF
Nxera Pharma Co Ltd, formerly known as Sosei Group Corp, is a Japan-based company engaged in the biopharmaceutical business that handles from drug research (drug discovery) to development and sale. The Company is mainly engaged in the pharmaceutical business. The Company is engaged in drug discovery, translational medicine, preclinical and early clinical development, as well as the research and development, import/export, packaging, and sale of pharmaceuticals. The Company also conducts structural analysis of G protein-coupled receptors (GPCRs), creates initial lead compounds, and searches for candidate products using StaR technology.